Combination of endocrine therapy, gonadotropin-releasing hormone agonist, and immunotherapy enhance immune activation in premenopausal ER+/HER2- metastatic breast cancer patients: final updates from PEER study

First Author / 第一作者

I-Chun Chen

Institution / 單位

Department of Medical Oncology, National Taiwan University Cancer Center

Audio / 音訊檔

Author Group / 作者群

Department of Oncology

Author Group Institution/ 作者群單位

National Taiwan University Hospital/ National Taiwan University Cancer Center

Category / 主題分類

Clinical Research

Keyword / 關鍵字

Immunotherapy, GnRH agonist, immune activation, ER positive metastatic breast cancer

Back to list